Acquisition of ByoFresh
04 Febbraio 2010 - 10:42AM
UK Regulatory
TIDMBYOT
RNS Number : 6801G
Byotrol PLC
04 February 2010
4 February 2010
Byotrol plc
ByoFresh acquisition
The Board of Byotrol plc ('Byotrol' or the 'Company'), the leading
anti-microbial hygiene company, is pleased to announce the acquisition of the
business and certain assets of Byofresh Limited (ByoFresh).
ByoFresh is a specialist pet care product business supplying an extensive range
of pet grooming and hygiene products to professional and domestic customers,
both through direct sale and through retailers. In 2006 ByoFresh became an
early adopter of Byotrol's technology and has since been recognised for the
quality and effectiveness of its products by industry experts, including being
awarded 'Glee Pet Index Highly Commended New Product Of The Year 2006' and 'Pets
At Home Supplier Best New Product 2007.'
Paul Foden, Managing Director of ByoFresh, qualified as a Chartered Accountant
with Arthur Andersen before joining their management consultancy arm Accenture.
Since leaving Accenture Mr Foden has spent the last six years building ByoFresh
into a successful supplier of pet products.
The ByoFresh business is a good strategic fit to Byotrol's stated strategy of
selling Byotrol based products through specialist distributors into niche
markets. The global pet care products market is estimated at GBP12 billion
annually.
Having shown success in the UK markets, ByoFresh will benefit significantly from
the additional resources and industry contacts available at Byotrol. Byotrol
will add a worldwide marketing capability to the ByoFresh product range which
will accelerate the distribution capability considerably.
The unaudited results for ByoFresh for the year ended 30 June 2009 show turnover
of GBP0.657m compared to GBP0.369m in the year ended 30 June 2008, with gross
profit of GBP0.158m and GBP0.140m respectively. Operating loss for 2009 was
GBP(0.092)m and GBP(0.036)m in 2008, resulting in respective operating margins
of (13.98)% and (9.78)%. It is anticipated that ByoFresh will make a positive
contribution in the next financial year.
The consideration for the acquisition will be satisfied, at completion, by the
issue of 400,000 ordinary shares in Byotrol. In addition, an anticipated
GBP31,008 will be paid for certain acquired fixed assets. The modest additional
cash requirement incurred in the current financial year following the
acquisition will be covered by the payment received from the recently announced
US option agreement announced on 21 December 2009. The Company has entered into
a service contract with Mr Foden which will permit him, subject to certain
profit and revenue targets, to earn bonuses of up to a maximum, in aggregate,
GBP1.75 million, which will only be achieved if ByoFresh achieves a significant
uplift in performance both against historic measures and the Board's forecasts
in the three years following completion. Payment will be made in shares and/or
cash at the Company's election.
Application will be made to the London Stock Exchange for the new ordinary
shares to be admitted to trading on AIM. It is expected that Admission will
become effective and that trading in the new ordinary shares will commence on
AIM at 8.00 a.m. on 10 February 2010. Following the issue of these shares, the
Company will have 84,116,411 ordinary shares in issue each share holding one
voting right.
The new ordinary shares will, when issued and fully paid, rank pari passu in all
respects with the existing ordinary shares, including the right to receive any
dividend or other distribution declared, made or paid after the date of their
unconditional allotment.
David McRobbie, Chief Executive of Byotrol, commented:
"We have been working closely with ByoFresh for a number of years and have
established the significant potential for ByoFresh in the pet care market.
"The pet care industry's recognition of the superior performance and long
lasting effectiveness of ByoFresh products is a valuable endorsement. We at
Byotrol are keen to ensure that we maximise the opportunity in that market for
Byotrol based products."
Enquiries:
David McRobbie, Chief Executive
0161 277 9518
Stephen Falder, Deputy Chairman
Richard Bell, Finance Director
Byotrol plc
Russell Cook / Carl Holmes
020 7149 6000
Charles Stanley Securities
Nominated Adviser
Tom Cooper / Paul Vann
020 3043 4162
Winningtons
0797 122 1972
Notes to Editors:
Byotrol Plc (BYOT.L), quoted on AIM, is a leading microbial technology hygiene
company, operating globally in the Health, Food, Leisure, Consumer, Industrial
and Agriculture sectors, providing a low toxicity product with a broad-based and
long lasting efficacy across all microbial classes; bacteria, viruses, fungi,
moulds, microbacteria and algae.
The Byotrol product can be used as a stand alone product or as a complementary
biocide additive to existing products to improve their performance in personal
hygiene, domestic and industrial disinfection, odour control, food production
and food management.
Founded in 2005, the Company has prioritised the development of a technology
that creates easier, safer and cleaner lives through partnering with providers
of essential goods and services. Byotrol is the catalyst behind the aptly named
global 'Hygiene Revolution'.
For more information, please go to www.byotrol.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
ACQLIFSAFLISIII
Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Lug 2023 a Lug 2024